ZIM Laboratories Limited
NSE: ZIMLAB.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Anwar Siraj Daud
- Employees
- 556
- Headquarters
- Nagpur, India
- IPO year
- 2022
- Market cap
- ₹5.5B
- Website
- https://www.zimlab.in
Loading ZIMLAB…
Loading profile data…Frequently asked questions about ZIMLAB
What does ZIM Laboratories Limited (ZIMLAB.NS) do?
ZIM Laboratories Limited develops, manufactures, and supplies pharmaceutical formulation and pre formulation ingredients in India and internationally. The company provides technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for generic pharmaceutical products in semi-finished and finished categories/fo...
Where does ZIMLAB.NS trade?
ZIM Laboratories Limited (ZIMLAB.NS) trades on the National Stock Exchange of India.
What sector is ZIMLAB.NS in?
ZIM Laboratories Limited (ZIMLAB.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of ZIM Laboratories Limited?
Anwar Siraj Daud is the chief executive officer of ZIM Laboratories Limited (ZIMLAB.NS).
Where is ZIM Laboratories Limited headquartered?
ZIM Laboratories Limited is headquartered in India.
Does ZIMLAB.NS pay a dividend?
ZIM Laboratories Limited (ZIMLAB.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ZIMLAB.NS go public?
ZIM Laboratories Limited (ZIMLAB.NS) completed its initial public offering in 2022.